PetMed Express Inc (PETS) stock
PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3068% below fair value
$0.90+0.00 (+0.20%)
Close on Nov 17, 2026Market cap $19.50MP/E –Yield 0.00%
PetMed Express r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for PetMed Express
PetMed Express has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?